Cholera Vaccine (Oral Route) Market Report

Cholera Vaccine (Oral Route) Market - Global Professional Analysis and Forecast to 2026

  • POSTDATE：Jun 26, 2020
  • PAGES：174
  • REPORT CODE：GMM587183
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The worldwide Cholera Vaccine (Oral Route) market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 6.4% during the forecast period.

    This report presents the market size and development trends by detailing the Cholera Vaccine (Oral Route) market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Cholera Vaccine (Oral Route) market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Cholera Vaccine (Oral Route) industry and will help you to build a panoramic view of the industrial development.

    Cholera Vaccine (Oral Route) Market, By Type:

    • Shanchol

    • Dukoral

    • Vaxchora

    • Others

    Cholera Vaccine (Oral Route) Market, By Application:

    • Hospital

    • Research & Academic Laboratories

    • Pharmaceutical & Biotechnology Companies

    • Others

    Some of the leading players are as follows:

    • PaxVax

    • Sanofi

    • Valneva

    • EuBiologics

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Cholera Vaccine (Oral Route) Market

    • 1.3 Market Segment by Type

      • 1.3.1 Shanchol

      • 1.3.2 Dukoral

      • 1.3.3 Vaxchora

      • 1.3.4 Others

    • 1.4 Market Segment by Application

      • 1.4.1 Hospital

      • 1.4.2 Research & Academic Laboratories

      • 1.4.3 Pharmaceutical & Biotechnology Companies

      • 1.4.4 Others

    • 1.5 Market Segment by Regions

      • 1.5.1 North America Cholera Vaccine (Oral Route) Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Cholera Vaccine (Oral Route) Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Cholera Vaccine (Oral Route) Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 LAMEA Cholera Vaccine (Oral Route) Consumption Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Cholera Vaccine (Oral Route) Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Cholera Vaccine (Oral Route) by Major Types

      • 3.4.1 Shanchol

      • 3.4.2 Dukoral

      • 3.4.3 Vaxchora

      • 3.4.4 Others

    4 Segmentation of Cholera Vaccine (Oral Route) Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Cholera Vaccine (Oral Route) by Major End-Users

      • 4.4.1 Hospital

      • 4.4.2 Research & Academic Laboratories

      • 4.4.3 Pharmaceutical & Biotechnology Companies

      • 4.4.4 Others

    5 Market Analysis by Major Regions

    • 5.1 Global Cholera Vaccine (Oral Route) Production Analysis by Top Regions

    • 5.2 Global Cholera Vaccine (Oral Route) Consumption Analysis by Top Regions

    • 5.3 Global Cholera Vaccine (Oral Route) Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Cholera Vaccine (Oral Route) Production, Import, Consumption and Export Analysis

      • 5.3.2 Europe Cholera Vaccine (Oral Route) Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Cholera Vaccine (Oral Route) Production, Import, Consumption and Export Analysis

      • 5.3.4 LAMEA Cholera Vaccine (Oral Route) Production, Import, Consumption and Export Analysis

    6 Product Circulation of Cholera Vaccine (Oral Route) Market among Top Countries

    • 6.1 Top 5 Export Countries in Cholera Vaccine (Oral Route) Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Cholera Vaccine (Oral Route) Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Cholera Vaccine (Oral Route) Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Cholera Vaccine (Oral Route) Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Cholera Vaccine (Oral Route) Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Cholera Vaccine (Oral Route) Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. North America Cholera Vaccine (Oral Route) Landscape Analysis

    • 7.1 North America Cholera Vaccine (Oral Route) Landscape Analysis by Top Countries

      • 7.1.1 United States Cholera Vaccine (Oral Route) Market Volume and Growth Rate

      • 7.1.2 Canada Cholera Vaccine (Oral Route) Market Volume and Growth Rate

      • 7.1.3 Mexico Cholera Vaccine (Oral Route) Market Volume and Growth Rate

    8. Europe Cholera Vaccine (Oral Route) Landscape Analysis

    • 8.1 Europe Cholera Vaccine (Oral Route) Landscape Analysis by Major Types

    • 8.2 Europe Cholera Vaccine (Oral Route) Landscape Analysis by Major End-Users

    • 8.3 Europe Cholera Vaccine (Oral Route) Landscape Analysis by Top Countries

      • 8.3.1 Germany Cholera Vaccine (Oral Route) Market Volume and Growth Rate

      • 8.3.2 UK Cholera Vaccine (Oral Route) Market Volume and Growth Rate

      • 8.3.3 France Cholera Vaccine (Oral Route) Market Volume and Growth Rate

      • 8.3.4 Italy Cholera Vaccine (Oral Route) Market Volume and Growth Rate

      • 8.3.5 Spain Cholera Vaccine (Oral Route) Market Volume and Growth Rate

      • 8.3.6 Belgium Cholera Vaccine (Oral Route) Market Volume and Growth Rate

      • 8.3.7 Poland Cholera Vaccine (Oral Route) Market Volume and Growth Rate

      • 8.3.8 Russia Cholera Vaccine (Oral Route) Market Volume and Growth Rate

      • 8.3.9 Turkey Cholera Vaccine (Oral Route) Market Volume and Growth Rate

      • 8.3.10 Netherlands Cholera Vaccine (Oral Route) Market Volume and Growth Rate

      • 8.3.11 Portugal Cholera Vaccine (Oral Route) Market Volume and Growth Rate

      • 8.3.12 Denmark Cholera Vaccine (Oral Route) Market Volume and Growth Rate

      • 8.3.13 Finland Cholera Vaccine (Oral Route) Market Volume and Growth Rate

      • 8.3.14 Iceland Cholera Vaccine (Oral Route) Market Volume and Growth Rate

      • 8.3.15 Norway Cholera Vaccine (Oral Route) Market Volume and Growth Rate

      • 8.3.16 Sweden Cholera Vaccine (Oral Route) Market Volume and Growth Rate

    • 8.4 Top 3 Players Profiles in Europe

    9 Asia Pacific Cholera Vaccine (Oral Route) Landscape Analysis

    • 9.1 Asia Pacific Cholera Vaccine (Oral Route) Landscape Analysis by Top Countries

      • 9.1.1 China Cholera Vaccine (Oral Route) Market Volume and Growth Rate

      • 9.1.2 Japan Cholera Vaccine (Oral Route) Market Volume and Growth Rate

      • 9.1.3 Australia and New Zealand (ANZ) Cholera Vaccine (Oral Route) Market Volume and Growth Rate

      • 9.1.4 India Cholera Vaccine (Oral Route) Market Volume and Growth Rate

      • 9.1.5 ASEAN Cholera Vaccine (Oral Route) Market Volume and Growth Rate

      • 9.1.6 South Korea Cholera Vaccine (Oral Route) Market Volume and Growth Rate

    10 LAMEA Cholera Vaccine (Oral Route) Landscape Analysis

    • 10.1 LAMEA Cholera Vaccine (Oral Route) Landscape Analysis by Top Countries

      • 10.1.1 GCC Countries Cholera Vaccine (Oral Route) Market Volume and Growth Rate

      • 10.1.2 Brazil Cholera Vaccine (Oral Route) Market Volume and Growth Rate

      • 10.1.3 North Africa Cholera Vaccine (Oral Route) Market Volume and Growth Rate

      • 10.1.4 South Africa Cholera Vaccine (Oral Route) Market Volume and Growth Rate

      • 10.1.5 Argentina Cholera Vaccine (Oral Route) Market Volume and Growth Rate

    11 Major Players Profiles

    • 11.1 PaxVax

      • 11.1.1 PaxVax Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Sanofi

      • 11.2.1 Sanofi Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Valneva

      • 11.3.1 Valneva Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 EuBiologics

      • 11.4.1 EuBiologics Company Profile and Recent Development

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 123 Figures and 154 Tables)

    • Figure Product Picture

    • Figure Market Size and Growth Rate of Shanchol

    • Figure Market Size and Growth Rate of Dukoral

    • Figure Market Size and Growth Rate of Vaxchora

    • Figure Market Size and Growth Rate of Others

    • Figure Market Size and Growth Rate of Hospital

    • Figure Market Size and Growth Rate of Research & Academic Laboratories

    • Figure Market Size and Growth Rate of Pharmaceutical & Biotechnology Companies

    • Figure Market Size and Growth Rate of Others

    • Figure North America Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

    • Figure United States Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

    • Figure UK Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

    • Figure France Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

    • Figure China Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

    • Figure Australia Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

    • Figure India Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

    • Figure LAMEA Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

    • Figure North Africa Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Cholera Vaccine (Oral Route) Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Cholera Vaccine (Oral Route) Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Cholera Vaccine (Oral Route)

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Cholera Vaccine (Oral Route) by Different Types from 2014 to 2026

    • Table Consumption Share of Cholera Vaccine (Oral Route) by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Shanchol

    • Figure Market Size and Growth Rate of Dukoral

    • Figure Market Size and Growth Rate of Vaxchora

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Cholera Vaccine (Oral Route) by Different End-Users from 2014 to 2026

    • Table Consumption Share of Cholera Vaccine (Oral Route) by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Hospital

    • Figure Market Size and Growth Rate of Research & Academic Laboratories

    • Figure Market Size and Growth Rate of Pharmaceutical & Biotechnology Companies

    • Figure Market Size and Growth Rate of Others

    • Table Global Cholera Vaccine (Oral Route) Production by Major Regions

    • Table Global Cholera Vaccine (Oral Route) Production Share by Major Regions

    • Table Global Cholera Vaccine (Oral Route) Consumption by Major Regions

    • Table Global Cholera Vaccine (Oral Route) Consumption Share by Major Regions

    • Table North America Cholera Vaccine (Oral Route) Production, Import, Consumption and Export Analysis

    • Table Europe Cholera Vaccine (Oral Route) Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Cholera Vaccine (Oral Route) Production, Import, Consumption and Export Analysis

    • Table LAMEA Cholera Vaccine (Oral Route) Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Cholera Vaccine (Oral Route) Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Cholera Vaccine (Oral Route) Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Cholera Vaccine (Oral Route) Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Cholera Vaccine (Oral Route) Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Cholera Vaccine (Oral Route) Consumption by Major Countries from 2014 to 2026

    • Table North America Cholera Vaccine (Oral Route) Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Cholera Vaccine (Oral Route) Consumption Share by Major Countries in 2014

    • Figure North America Cholera Vaccine (Oral Route) Consumption Share by Major Countries in 2018

    • Figure North America Cholera Vaccine (Oral Route) Consumption Share by Major Countries in 2026

    • Figure United States Cholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Cholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Cholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Cholera Vaccine (Oral Route) Consumption by Types from 2014 to 2026

    • Table Europe Cholera Vaccine (Oral Route) Consumption Share by Types from 2014 to 2026

    • Table Europe Cholera Vaccine (Oral Route) Consumption by End-Users from 2014 to 2026

    • Table Europe Cholera Vaccine (Oral Route) Consumption Share by End-Users from 2014 to 2026

    • Table Europe Cholera Vaccine (Oral Route) Consumption by Major Countries from 2014 to 2026

    • Table Europe Cholera Vaccine (Oral Route) Consumption Share by Major Countries from 2014 to 2026

    • Figure Germany Cholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Cholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

    • Figure France Cholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Cholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Cholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

    • Figure Spain Cholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Cholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Cholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Cholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Cholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Cholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

    • Figure Portugal Cholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

    • Figure Denmark Cholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Cholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Cholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Cholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Cholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Cholera Vaccine (Oral Route) Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Cholera Vaccine (Oral Route) Consumption Share by Major Countries from 2014 to 2026

    • Figure China Cholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Cholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia Cholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

    • Figure India Cholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Cholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Cholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Cholera Vaccine (Oral Route) Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Cholera Vaccine (Oral Route) Consumption Share by Major Countries from 2014 to 2026

    • Figure GCC Countries Cholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Countries Cholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

    • Figure North Africa Countries Cholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Countries Cholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Countries Cholera Vaccine (Oral Route) Market Volume and Growth Rate from 2014 to 2026

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of PaxVax

    • Figure Sales and Growth Rate Analysis of PaxVax

    • Figure Revenue and Market Share Analysis of PaxVax

    • Table Product and Service Introduction of PaxVax

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Valneva

    • Figure Sales and Growth Rate Analysis of Valneva

    • Figure Revenue and Market Share Analysis of Valneva

    • Table Product and Service Introduction of Valneva

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of EuBiologics

    • Figure Sales and Growth Rate Analysis of EuBiologics

    • Figure Revenue and Market Share Analysis of EuBiologics

    • Table Product and Service Introduction of EuBiologics

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US